Temozolomide - Merck & Co
At a glance
- Drug Originator Cancer Research UK
- Drug Licenced by Merck & Co
- Drug Class 2 ring heterocyclic compounds; Amides; Antineoplastics; Imidazoles; Small molecules; Triazenes
- Mechanism of Action Alkylating agents; DNA cross linking agents; DNA synthesis inhibitors
- USA Patent Applicants MERCK SHARP DOHME
- USA Patents 4
- NDAs 2
- Patent Applications 2,594
Table of Contents
Disclaimer